"Huntington Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A familial disorder inherited as an autosomal dominant trait and characterized by the onset of progressive CHOREA and DEMENTIA in the fourth or fifth decade of life. Common initial manifestations include paranoia; poor impulse control; DEPRESSION; HALLUCINATIONS; and DELUSIONS. Eventually intellectual impairment; loss of fine motor control; ATHETOSIS; and diffuse chorea involving axial and limb musculature develops, leading to a vegetative state within 10-15 years of disease onset. The juvenile variant has a more fulminant course including SEIZURES; ATAXIA; dementia; and chorea. (From Adams et al., Principles of Neurology, 6th ed, pp1060-4)
Descriptor ID |
D006816
|
MeSH Number(s) |
C10.228.140.079.545 C10.228.140.380.278 C10.228.662.262.249.750 C10.574.500.497 C16.320.400.430 F03.615.250.400 F03.615.400.390
|
Concept/Terms |
Huntington Disease- Huntington Disease
- Huntington Chorea
- Chorea, Huntington
- Huntington's Disease
- Chronic Progressive Hereditary Chorea (Huntington)
- Huntington Chronic Progressive Hereditary Chorea
- Progressive Chorea, Chronic Hereditary (Huntington)
- Progressive Chorea, Hereditary, Chronic (Huntington)
- Huntington's Chorea
- Chorea, Huntington's
- Chorea, Chronic Progressive Hereditary (Huntington)
Juvenile Huntington Disease- Juvenile Huntington Disease
- Juvenile-Onset Huntington Disease
- Juvenile Onset Huntington Disease
- Huntington Disease, Juvenile-Onset
- Huntington Disease, Juvenile Onset
- Huntington Disease, Juvenile
|
Below are MeSH descriptors whose meaning is more general than "Huntington Disease".
Below are MeSH descriptors whose meaning is more specific than "Huntington Disease".
This graph shows the total number of publications written about "Huntington Disease" by people in this website by year, and whether "Huntington Disease" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1997 | 2 | 0 | 2 |
1998 | 1 | 1 | 2 |
2000 | 2 | 1 | 3 |
2001 | 0 | 1 | 1 |
2002 | 1 | 0 | 1 |
2003 | 1 | 0 | 1 |
2004 | 2 | 0 | 2 |
2006 | 3 | 0 | 3 |
2007 | 4 | 1 | 5 |
2008 | 2 | 0 | 2 |
2009 | 2 | 0 | 2 |
2010 | 2 | 0 | 2 |
2011 | 1 | 0 | 1 |
2014 | 2 | 0 | 2 |
2015 | 2 | 0 | 2 |
2016 | 2 | 0 | 2 |
2017 | 3 | 0 | 3 |
2018 | 2 | 0 | 2 |
2020 | 2 | 0 | 2 |
2021 | 3 | 0 | 3 |
2022 | 2 | 0 | 2 |
2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Huntington Disease" by people in Profiles.
-
Defining Clinical Meaningfulness in Huntington's Disease. Mov Disord. 2023 06; 38(6):1036-1043.
-
Postural control and gait measures derived from wearable inertial measurement unit devices in Huntington's disease: Recommendations for clinical outcomes. Clin Biomech (Bristol, Avon). 2022 06; 96:105658.
-
Advance Directive Documentation in a Huntington's Disease Clinic: A Retrospective Chart Review. Tremor Other Hyperkinet Mov (N Y). 2022; 12:4.
-
Evaluation of gait initiation using inertial sensors in Huntington's Disease: insights into anticipatory postural adjustments and cognitive interference. Gait Posture. 2021 06; 87:117-122.
-
Reply to: "Cell Therapy for Huntington's Disease: Learning from Failure". Mov Disord. 2021 03; 36(3):788-789.
-
Alleviation of Huntington pathology in mice by oral administration of food additive glyceryl tribenzoate. Neurobiol Dis. 2021 06; 153:105318.
-
A Failed Future. Mov Disord. 2020 08; 35(8):1299-1301.
-
The effects of dual-task cognitive interference on gait and turning in Huntington's disease. PLoS One. 2020; 15(1):e0226827.
-
Quality of Life in Huntington's Disease: Critique and Recommendations for Measures Assessing Patient Health-Related Quality of Life and Caregiver Quality of Life. Mov Disord. 2018 05; 33(5):742-749.
-
Disease Modification Through Trophic Factor Delivery. Methods Mol Biol. 2018; 1780:525-547.